To further validate this, ameloblastoma tumour masses cultured alongside different stroma were tested for the expression of RANKL (TNFSF11) which is the main mechanism identified for ameloblastoma-induced bone resorption (Fig. 2D). This evidence concerns the gene TNFSF11 and neoplasm.